Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Alimta and Carboplatin in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer

NCT00072865 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00072865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00072865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Alimta and Carboplatin in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
September 30, 2005
Enrollment
50
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neoplasm metastasis